Authors: | Zinkernagel, R. M.; Wolf, H.; Klasner, R. D.; Fauci, A. S.; Corey, L.; Nabel, G. J.; Gayle, H.; Berkley, S.; Haynes, B. F.; Baltimore, D.; Collins, C.; Douglas, R. G.; Esparza, J.; Francis, D. P.; Ganguly, N. K.; Gerberding, J. L.; Johnson, M. I.; Kazatchkine, M. D.; McMichael, A. J.; Makgoba, M. W.; Pantaleo, G.; Piot, P.; Shao, Y.; Tramont, E.; Varmus, H.; Wasserheit, J. N. |
Article Title: | The challenges of an HIV vaccine enterprise (multiple letters) |
Keywords: | disease course; human immunodeficiency virus infection; letter; drug research; cellular immunity; human immunodeficiency virus; vaccine production; health care planning; policy; drug industry; neutralizing antibody; biomedicine; human immunodeficiency virus vaccine; human; priority journal |
Journal Title: | Science |
Volume: | 303 |
Issue: | 5662 |
ISSN: | 0036-8075 |
Publisher: | American Association for the Advancement of Science |
Date Published: | 2004-02-27 |
Start Page: | 1294 |
End Page: | 1297 |
Language: | English |
DOI: | 10.1126/science.303.5662.1294 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | Cited By (since 1996):6 -- Export Date: 16 June 2014 -- CODEN: SCIEA -- Source: Scopus |